Publication | Closed Access

Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells

MedicineLiver PhysiologyMef2d RegulationHepatocellular Carcinoma CellsCell DeathCheckpoint InhibitorLiver CancerCell BiologyTumor SuppressorOncologyRadiation OncologyHepatocellular CarcinomaCancer ResearchHealth Sciences